Molgramostim is used for the treatment of drug-induced decrease in white blood cell count (neutropenia), and to accelerate recovery chemotherapy-associated neutropenia and bone marrow transplantation associated complications.
How it works
Molgramostim belongs to class of drugs called granulocyte-macrophage colony-stimulating factor (GM-CSF). It acts as a growth factor and increases the production of white blood cells in the bone marrow.
Common side effects
Abdominal pain, Chest pain, Confusion, Diarrhoea, Dizziness, Shortness of breath, Fainting, Fatigue, Headache, Decreased blood pressure, Increased sweating, Itching, Loss of appetite, Loss of consciousness, Nausea, Rash, Feeling of cold, Stomatitis, Vomiting, Weakness
• Tell your doctor if you are having asthma or other lung diseases, heart disease, myeloid (bone marrow) cancer, kidney disease, liver disease or are undergoing radiation or chemotherapy.
• You will be regularly monitored for complete blood count during therapy.
• Tell your doctor if you are or planning to become pregnant or are breastfeeding.
• Patients with pre-existing breathing disorders, fluid retention, heart failure, blood cancers, lung malignancies should not take molgramostim.